Updated:
PanTheryx Inc.
PanTheryx is a Boulder nutrition and biotechnology company commercializing bovine colostrum into supplements, probiotics, and ingredients for human health.
PanTheryx Inc.
PanTheryx Inc., headquartered in Boulder, Colorado, positions itself as a nutrition and biotechnology company built around bovine colostrum. The company was launched with a focus on supplying colostrum ingredients and has since expanded into finished consumer health products. Its leadership includes Tom Feeley as President & CEO, alongside a board chaired by David Abramson, former president of Martek Biosciences. The firm operates across three business lines: direct-to-consumer branded supplements, contract manufacturing, and colostrum-derived ingredients for early-life nutrition and sports nutrition. Its portfolio includes TruBiotics daily probiotics (acquired from Bayer in an undisclosed deal), DiaResQ for digestive support, Life's First Naturals colostrum supplements, and Relesium targeting GLP-1 digestive side effects. PanTheryx sells in the United States and China via Alibaba's Tmall Global, and it markets Life's First Naturals PRO exclusively through health care practitioners. The company's website does not disclose AUM, revenue, or ownership structure. PanTheryx employs about ten named senior leaders, including finance, operations, and marketing functions. The company maintains a scientific advisory board staffed by colostrum researcher Raymond Playford, internal medicine physician Harry Oken, and Cleveland Clinic wellness expert Michael Roizen. In November 2024, PanTheryx added menopause specialist Jaime Seeman to its scientific advisory board. The board of directors includes principals from Pegasus Capital Advisors, which holds a stake in the company along with investment from firms such as Halo and HTS. PanTheryx is not a family office; it operates as a privately held operating company backed by institutional investors including Pegasus Capital Advisors. Its structural differentiator lies in vertical integration from raw colostrum collection through finished product manufacturing and scientific advisory. The company runs a farmer-partner network for colostrum sourcing, toll manufacturing for third-party brands, and its own clinical research program.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Boulder
Corporate office
4845 Pearl East Circle, Suite 101, Boulder, CO 80301, United States
Principals
Tom Feeley
President & Chief Executive Officer
Raymond Playford
Medical Director
Amy Gibbs
VP of Finance
Brian Aller
Senior Director of Operations
Whitney Callahan
Director of Marketing
Sector focus
Frequently asked questions
Who makes investment decisions at PanTheryx?
Operational decisions are made by Tom Feeley, President & CEO. The company is privately held; its board includes representatives from Pegasus Capital Advisors, which holds an ownership stake. PanTheryx does not publish a separate investment committee for external capital allocation (per firm website).
Is PanTheryx a family office or a private operating company?
PanTheryx is a private operating company, not a family office. It is backed by institutional investors including Pegasus Capital Advisors. The firm's primary business is developing, manufacturing, and selling colostrum-based nutritional products (per firm website and board biographies).
What brands does PanTheryx own?
PanTheryx owns and markets TruBiotics probiotics (acquired from Bayer), DiaResQ digestive health supplements, Relesium for GLP-1 support, Life's First Naturals colostrum supplements, and Life's First Naturals PRO (healthcare practitioner channel). These are described on the company's website.
Does PanTheryx sell directly to consumers?
Yes. PanTheryx sells its branded supplements direct-to-consumer via e-commerce platforms including Amazon and Tmall Global in China, as well as through retail partners such as Walmart, Target, and Instacart. Its Life's First Naturals PRO line is exclusive to health care practitioners (per firm website marketing descriptions).
Where does PanTheryx source its colostrum?
PanTheryx operates a farmer-partner network for bovine colostrum collection. The company's website offers a farmer partnership program and highlights colostrum sourcing as part of its vertical integration model. Specific farm locations or volumes are not disclosed.
What is the ownership structure of PanTheryx?
PanTheryx is privately held. Its board includes David Abramson (Executive Chairman), David Cogut (a principal at Pegasus Capital Advisors), Peter Erickson (former General Mills executive), Holger Liepmann (former Abbott executive), and Stuart Harris (MGH physician). Pegasus Capital Advisors is a known equity investor. Specific ownership percentages are not publicly filed.
Has PanTheryx made any recent acquisitions?
Yes. PanTheryx acquired the TruBiotics probiotic brand from Bayer HealthCare LLC. The deal was announced on the company's website, but terms — including purchase price — were not disclosed. The acquisition expanded PanTheryx's digestive and immune health product lines.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: